Is the business good?
How good a business is JNJ?
Johnson & Johnson keeps 21% of every revenue dollar as profit after everything, against 18% for the median Drug Manufacturers - General name.
21%
Net margin · Drug Manufacturers - General median 18% · 12 months to Q2 2026
- Cash conversion
- 1.06×
Cash conversion · 0.82× a year ago · every dollar of reported profit arrived as cash, and more
- Share count, year on year
- +0.87%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 15%
R&D as % of revenue
Details›
- Gross margin12 months to Q2 2026
- 68%
- Net margin12 months to Q2 2026
- 21%
- Free cash flow margin
- 23%
- R&D as % of revenue
- 15%
- Revenue, trailing twelve months
- $97.9B
- Free cash flow, trailing twelve months
- $22.2B
- Net income, trailing twelve months
- $21.0B
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Drug Manufacturers - General
Ranks #2 of 16 by Smart Score